PET Radiopharmaceuticals Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281312 No. of Pages: 74 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of PET Radiopharmaceuticals in global, including the following market information:
Global PET Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PET Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five PET Radiopharmaceuticals companies in 2021 (%)
The global PET Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
F-18 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PET Radiopharmaceuticals include Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada) and Advanced Accelerator Applications S.A. (France) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PET Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PET Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
F-18
Ru-82
Others
Global PET Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiology
Neurology
Others
Global PET Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PET Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PET Radiopharmaceuticals revenues share in global market, 2021 (%)
Key companies PET Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies PET Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
1 Introduction to Research & Analysis Reports
1.1 PET Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PET Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PET Radiopharmaceuticals Overall Market Size
2.1 Global PET Radiopharmaceuticals Market Size: 2021 VS 2028
2.2 Global PET Radiopharmaceuticals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PET Radiopharmaceuticals Sales: 2017-2028
3 Company Landscape
3.1 Top PET Radiopharmaceuticals Players in Global Market
3.2 Top Global PET Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global PET Radiopharmaceuticals Revenue by Companies
3.4 Global PET Radiopharmaceuticals Sales by Companies
3.5 Global PET Radiopharmaceuticals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PET Radiopharmaceuticals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PET Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 PET Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 PET Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 PET Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global PET Radiopharmaceuticals Market Size Markets, 2021 & 2028
4.1.2 F-18
4.1.3 Ru-82
4.1.4 Others
4.2 By Type - Global PET Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global PET Radiopharmaceuticals Revenue, 2017-2022
4.2.2 By Type - Global PET Radiopharmaceuticals Revenue, 2023-2028
4.2.3 By Type - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
4.3 By Type - Global PET Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global PET Radiopharmaceuticals Sales, 2017-2022
4.3.2 By Type - Global PET Radiopharmaceuticals Sales, 2023-2028
4.3.3 By Type - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
4.4 By Type - Global PET Radiopharmaceuticals Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global PET Radiopharmaceuticals Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Neurology
5.1.5 Others
5.2 By Application - Global PET Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global PET Radiopharmaceuticals Revenue, 2017-2022
5.2.2 By Application - Global PET Radiopharmaceuticals Revenue, 2023-2028
5.2.3 By Application - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
5.3 By Application - Global PET Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global PET Radiopharmaceuticals Sales, 2017-2022
5.3.2 By Application - Global PET Radiopharmaceuticals Sales, 2023-2028
5.3.3 By Application - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
5.4 By Application - Global PET Radiopharmaceuticals Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global PET Radiopharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global PET Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global PET Radiopharmaceuticals Revenue, 2017-2022
6.2.2 By Region - Global PET Radiopharmaceuticals Revenue, 2023-2028
6.2.3 By Region - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
6.3 By Region - Global PET Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global PET Radiopharmaceuticals Sales, 2017-2022
6.3.2 By Region - Global PET Radiopharmaceuticals Sales, 2023-2028
6.3.3 By Region - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PET Radiopharmaceuticals Revenue, 2017-2028
6.4.2 By Country - North America PET Radiopharmaceuticals Sales, 2017-2028
6.4.3 US PET Radiopharmaceuticals Market Size, 2017-2028
6.4.4 Canada PET Radiopharmaceuticals Market Size, 2017-2028
6.4.5 Mexico PET Radiopharmaceuticals Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PET Radiopharmaceuticals Revenue, 2017-2028
6.5.2 By Country - Europe PET Radiopharmaceuticals Sales, 2017-2028
6.5.3 Germany PET Radiopharmaceuticals Market Size, 2017-2028
6.5.4 France PET Radiopharmaceuticals Market Size, 2017-2028
6.5.5 U.K. PET Radiopharmaceuticals Market Size, 2017-2028
6.5.6 Italy PET Radiopharmaceuticals Market Size, 2017-2028
6.5.7 Russia PET Radiopharmaceuticals Market Size, 2017-2028
6.5.8 Nordic Countries PET Radiopharmaceuticals Market Size, 2017-2028
6.5.9 Benelux PET Radiopharmaceuticals Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PET Radiopharmaceuticals Revenue, 2017-2028
6.6.2 By Region - Asia PET Radiopharmaceuticals Sales, 2017-2028
6.6.3 China PET Radiopharmaceuticals Market Size, 2017-2028
6.6.4 Japan PET Radiopharmaceuticals Market Size, 2017-2028
6.6.5 South Korea PET Radiopharmaceuticals Market Size, 2017-2028
6.6.6 Southeast Asia PET Radiopharmaceuticals Market Size, 2017-2028
6.6.7 India PET Radiopharmaceuticals Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PET Radiopharmaceuticals Revenue, 2017-2028
6.7.2 By Country - South America PET Radiopharmaceuticals Sales, 2017-2028
6.7.3 Brazil PET Radiopharmaceuticals Market Size, 2017-2028
6.7.4 Argentina PET Radiopharmaceuticals Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PET Radiopharmaceuticals Sales, 2017-2028
6.8.3 Turkey PET Radiopharmaceuticals Market Size, 2017-2028
6.8.4 Israel PET Radiopharmaceuticals Market Size, 2017-2028
6.8.5 Saudi Arabia PET Radiopharmaceuticals Market Size, 2017-2028
6.8.6 UAE PET Radiopharmaceuticals Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Cardinal Health Inc. (U.S.)
7.1.1 Cardinal Health Inc. (U.S.) Corporate Summary
7.1.2 Cardinal Health Inc. (U.S.) Business Overview
7.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Major Product Offerings
7.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.1.5 Cardinal Health Inc. (U.S.) Key News
7.2 Mallinckrodt plc (Ireland)
7.2.1 Mallinckrodt plc (Ireland) Corporate Summary
7.2.2 Mallinckrodt plc (Ireland) Business Overview
7.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Major Product Offerings
7.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.2.5 Mallinckrodt plc (Ireland) Key News
7.3 GE Healthcare (U.K.)
7.3.1 GE Healthcare (U.K.) Corporate Summary
7.3.2 GE Healthcare (U.K.) Business Overview
7.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Major Product Offerings
7.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.3.5 GE Healthcare (U.K.) Key News
7.4 Lantheus Medical Imaging, Inc. (U.S.)
7.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporate Summary
7.4.2 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
7.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Major Product Offerings
7.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.4.5 Lantheus Medical Imaging, Inc. (U.S.) Key News
7.5 Bayer AG (Germany)
7.5.1 Bayer AG (Germany) Corporate Summary
7.5.2 Bayer AG (Germany) Business Overview
7.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Major Product Offerings
7.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.5.5 Bayer AG (Germany) Key News
7.6 Bracco Imaging S.p.A (Italy)
7.6.1 Bracco Imaging S.p.A (Italy) Corporate Summary
7.6.2 Bracco Imaging S.p.A (Italy) Business Overview
7.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Major Product Offerings
7.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.6.5 Bracco Imaging S.p.A (Italy) Key News
7.7 Eczacibasi-Monrol Nuclear Products (Turkey)
7.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporate Summary
7.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
7.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Major Product Offerings
7.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Key News
7.8 Nordion, Inc. (Canada)
7.8.1 Nordion, Inc. (Canada) Corporate Summary
7.8.2 Nordion, Inc. (Canada) Business Overview
7.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Major Product Offerings
7.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.8.5 Nordion, Inc. (Canada) Key News
7.9 Advanced Accelerator Applications S.A. (France)
7.9.1 Advanced Accelerator Applications S.A. (France) Corporate Summary
7.9.2 Advanced Accelerator Applications S.A. (France) Business Overview
7.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Major Product Offerings
7.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.9.5 Advanced Accelerator Applications S.A. (France) Key News
7.10 IBA Molecular Imaging (Belgium)
7.10.1 IBA Molecular Imaging (Belgium) Corporate Summary
7.10.2 IBA Molecular Imaging (Belgium) Business Overview
7.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Major Product Offerings
7.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.10.5 IBA Molecular Imaging (Belgium) Key News
8 Global PET Radiopharmaceuticals Production Capacity, Analysis
8.1 Global PET Radiopharmaceuticals Production Capacity, 2017-2028
8.2 PET Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global PET Radiopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET Radiopharmaceuticals Supply Chain Analysis
10.1 PET Radiopharmaceuticals Industry Value Chain
10.2 PET Radiopharmaceuticals Upstream Market
10.3 PET Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PET Radiopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com